$11.97
-0.47-3.78%
À la clôture: Nov 20, 4:00 PM EST
$12.00
0.030.25%
Après les heures: Nov 20, 7:22 AM EST
The average analyst price target for Ascentage Pharma Group is $44.56, 271.3% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $33 to $51. The latest change came on Oct 16, 2026, when William Blair initiated coverage of Ascentage Pharma Group with an Outperform rating.
Price Target Range — 5 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
